Baker Bros. Advisors LP Exact Sciences Corp Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $184 Million - $262 Million
-1,846,139 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $28 Million - $77.2 Million
-739,652 Reduced 28.6%
1,846,139 $107 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $201 Million - $258 Million
2,585,791 New
2,585,791 $239 Million

Others Institutions Holding EXAS

# of Institutions
670
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email